Federation Des Caisses Desjardins Du Quebec Vertex Pharmaceuticals Inc Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 53,236 shares of VRTX stock, worth $25.8 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
53,236
Previous 39,487
34.82%
Holding current value
$25.8 Million
Previous $18.4 Million
16.74%
% of portfolio
0.12%
Previous 0.1%
Shares
31 transactions
Others Institutions Holding VRTX
# of Institutions
1,768Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.7 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.3 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.81 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.06 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...